Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Drug Delivery in Paediatric Brain Tumours /
Intrathecal drug delivery to brain tumours

1st - 2nd Feb 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.02.16
Views: 1717

Mr Donald Macarthur - University Hospital Nottingham, Nottingham, UK

Mr Macarthur talks to ecancertv at Children with Cancer UK’s workshop on Drug Delivery in Paediatric Brain Tumours in London, UK.

He discusses his experience of intrathecal administration of chemotherapy to target brain tumours in children.

Getting treatment across the blood-brain barrier is one of the challenges when treating childhood brain cancers, he observes, and injecting chemotherapy into the cerebral spinal fluid is one possible way around this.

Although not a first-line approach, it is potentially suitable for brain tumours that have metastasised, with medulloblastomas and ependymoma the most common tumour types treated so far in Nottingham.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation